Top Markets
Coin of the day
Duality Biotherapeutics, Inc. Duality Biotherapeutics, Inc.

Duality Biotherapeutics, Inc.

9606
Clasificación en acciones #6046
Operating as a clinical-stage enterprise, Duality Biotherapeutics, Inc.... Operating as a clinical-stage enterprise, Duality Biotherapeutics, Inc. concentrates on pioneering next-generation antibody-drug conjugate (ADC) therapies and proprietary duality immune toxin antibody conjugate (ITAC) solutions. The firm was founded by Zhu Zhong Yuan on July 3, 2019, and its main offices are situated in Shanghai, China.
Precio por acción
$25.01
Capitalización bursátil
$2.26B
Cambio (1 día)
-1.21%
Cambio (1 año)
-37.74%
País
CN
Comercio Duality Biotherapeutics, Inc. (9606)

Categoría

Ganancias de Duality Biotherapeutics, Inc. (9606)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Duality Biotherapeutics, Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Duality Biotherapeutics, Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$5.27B -
US
$1.95B -
NL
$-4.02B -
AU
$-3.09B -
US
- -
CH